POSTER SESSION III
Tuesday, March 20, 2012   —  9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


BREAST PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
13 Incidence of an Anatomically Separate Carcinoma of the Breast in Patients Diagnosed with a Papillary Lesion on Breast Core Biopsy (113)
M Chung, N Shapiro, T Koenigsberg, S Fineberg - Montefiore Medical Center, Bronx, NY 		Add
14 Surgical Excision May Not Be Necessary for Benign Papillomas on Core Biopsy: A Large Retrospective Study in an Academic Women Center (195)
X Li, M Desouki, D Dabbs, S Shyu, G Carter, L Wang, C Zhao - Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA 		Add
15 Pathologic Upgrade (PU) Rates on Subsequent Excisional Biopsy (EXBX) When Lobular Carcinoma In Situ (LCIS) Is Found in a Needle Core Biopsy (NCB) with Emphasis on Radiologic Correlation (121)
TM DŽAlfonso, K Wang, Y-L Chiu, SJ Shin - Weill Cornell Medical College, New York, NY; Cornell University, Ithaca, NY 		Add
16 ŽIncidentalŽ Intraductal Papillomas: Is Excision Necessary? (291)
PS Weisman, BJ Sutton, KP Siziopikou, J Franz, SM Rohan, ME Sullivan - Northwestern University, Chicago, IL 		Add
17 Breast Papillary Lesion on Needle Core Biopsy: Is Surgical Excision Necessary? (203)
L Lopez, K Woolf, D Hicks, X Wang - University of Rochester, Rochester 		Add
18 Evaluation of 2358 Breast Needle Biopsy Cases: Patients with Pure Atypical Flat Lesions Could Be Spared Surgical Excision (300)
R Yamaguchi, M Tanaka, J Akiba, Y Naito, H Yano - Kurume University School of Medicine, Kurume, Japan; Social Insurance Kurume Daiichi Hospital, Kurume, Japan 		Add
19 Radial Scar at Image-Guided Needle Biopsy: Is Follow-Up Excision Always Necessary? (124)
C DŽArcy, L Liberman, T Nehhozina, E Brogi, AD Corben - Memorial Sloan Kettering Cancer Center, New York, NY 		Add
20 Histological Evaluation of the Papillary Lesions of the Breast from Needle Biopsy to the Excised Specimen: A Single Institutional Experience (158)
SM Gilani, RS Tashjian, PJ Kowalski - St. John Hospital & Medical Center, Detroit, MI 		Add
21 Mitotic Figure Counts Are Significantly Higher in Breast Cancer Tumorectomy Specimen Than to Needle Biopsies (259)
C Schaper, C Rochat, A Nobile, E Obermann, H-A Lehr - Breast Center Südbaden, Freiburg, Germany; CHUV, Lausanne, Switzerland; University Hospital, Basel, Switzerland 		Add
22 High Grade Lobular Carcinoma In Situ in Breast Excision: Potential for Misdiagnosis as Solid Type DCIS or Classical LCIS (161)
F Habib, S Syriac, D Wang, S Liu, R Karabakhtsian, D Tan, T Khoury - Roswell Park Cancer Institute, Buffalo, NY; University of Kentucky, Lexington, KY; MD Anderson Cancer Center, Houston, TX 		Add
23 Endoglin: An Adjunct Diagnostic Marker To Differentiate between Benign and Atypical Vascular Lesions/Proliferations Arising in the Breast Post-Radiation therapy (133)
W Dubinski, D Ghazarian - University Health Network, Toronto, Canada 		Add
24 Dual PTEN and RB Loss Predict Invasive Recurrence of DCIS (200)
RL Lipinski, RW OŽNeill, ES Knudsen, GF Schwartz, AK Witkiewicz - Thomas Jefferson University, Philadelphia, PA 		Add
25 Fascin Expression Associated with Triple Negative Breast Cancers and Unfavorable Prognosis in African-American Women (142)
AK Esnakula, LJ Ricks-Santi, W Frederick, TJ Naab - Howard University Hospital, Washington, DC; Howard University Cancer Center, Washington, DC 		Add
26 CD105 (Endoglin) Expression in Tumor Cells Associated with HER2 Positive Breast Cancers and Decreased Disease-Free Survival in African American Women (218)
TJ Naab, LJ Ricks-Santi, YM Kannan, AK Esnakula - Howard University Hospital, Washington, DC; Howard University Cancer Center, Washington, DC 		Add
27 Predictors of Response to Trastuzumab Containing Neoadjuvant Chemotherapy in HER2 Positive Breast Cancers (194)
X Li, A Kanbour-Shakir, D Dabbs, R Bhargava - University of Pittsburgh Medical Center, Pittsburgh, PA 		Add
28 HER2 Overexpression Is a Major Risk Factor for Recurrence in pT1a-b, N0 Breast Cancer: A French Regional Population- Based Study of 671 Patients (98)
F Bibeau, F Boissiere-Michot, A Denouel, V Szablewski, H Perrocchia, C Pignodel, A Gudin de Vallerin, C Leaha, M-C Chateau, G Barneon, P Vic, A Garnier, M Granier, P Roger - CRLCC Val dŽAurelle, Montpellier, Herault, France; Hôpital Gui de Chauliac, Montpellier, Herault, France; Groupe Hospitalo-Universitaire, Nîmes, Gard, France; Centre de Pathologie, Montpellier, Herault, France; CACP Les Tonnelles, Montpellier, Herault, France 		Add
29 Morphological Characteristics of HER2 Over-Expressing and Basal-Like Breast Cancers and the Association between Lymphocytic Tumor Infiltrate and Prognosis (93)
AL Bane, S Parpia, G Pond, V Kumar, G Gohla, MN Levine, T Whelan - McMaster University, Hamilton, ON, Canada 		Add
30 Progesterone Receptor and HER2 Status Are Significant Prognostic Factors in Advanced Breast Cancer (245)
Z Ren, O Hameed, Y Li, GP Siegal, S Wei - University of Alabama at Birmingham, Birmingham 		Add
31 HER2 Heterogeneity by FISH in Breast Cancers and Matched Lymph Node Metastases: A Pilot Study (274)
CJ Suarez, SM Dintzis, RA Schmidt, KH Allison - University of Washington, Seattle 		Add
32 DCIS Heterogeneity: An Integrated RNA-miRNA Analysis (215)
JC Moreno, R Nair, NA Miller, BJ Youngson, V Iakovlev, D McCready, SJ Done - Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; St. MichaelŽs Hospital, Toronto, ON, Canada 		Add
33 Molecular Difference between Pure Invasive Ductal Carcinoma (IDC) and the IDC Components of the Tumors with Co-Existing Ductal Carcinoma In Situ (125)
J Da, J Wang, H Chen, B Wei, DG Hicks, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solution, Research Triangle Park, NC 		Add
34 ZNF217 and FGFR1 Amplification in the Progression of In Situ to Invasive Breast Carcinoma (171)
M Jang, EJ Kim, Y Choi, HE Lee, SY Park - Seoul National University College of Medicine, Seoul, Republic of Korea; Seoul National University Hospital, Seoul, Republic of Korea; Seoul National University Bundang Hospital, Seongnam, Republic of Korea 		Add
35 Molecular Difference between the Components of the Ductal Carcinoma In Situ and the Invasive Ductal Carcinoma (IDC), and between the Components of the IDC and the Metastasis of the Same Breast Cancer Patients (290)
B Wei, J Wang, J Da, H Chen, DG Hicks, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solution, Research Triangle Park, NC 		Add
36 Meta-Analysis of Gene Expression Profiling Datasets To Uncover Biological Pathways and Candidate Biomarkers Associated with Progression in DCIS (250)
JN Robens, SJ Schnitt, AH Beck - Beth Israel Deaconess Medical Center, Boston 		Add
37 Comparison of FISH and SISH Methods for HER2 Testing in Breast Carcinoma: A Validation Study Emphasizing Automated Methods (105)
MC Chang, M Rogers, G Kuruzar, M Reid, M Mendes, P Plotnick, A Azad - Mount Sinai Hospital, Toronto, ON, Canada; Univ of Toronto, Toronto, ON, Canada 		Add